Literature DB >> 24433931

Non-motor symptoms of Parkinson's disease A review…from the past.

Pedro J Garcia-Ruiz1, K Ray Chaudhuri2, Pablo Martinez-Martin3.   

Abstract

Although Parkinson's disease (PD) has been classically defined as a motor disorder, a range of non-motor symptoms (NMS) including cognitive, mood, autonomic and sleep disturbances occur with the passage of time. Although it seems that the non-motor aspect of PD is a recent observation, classic authors (James Parkinson, Charcot, Gowers, Oppenheim and Wilson) had described many NMS including pain, fatigue, bladder dysfunction, cognitive decline and delusion. In this review we have collated the classic literature of NMS in PD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Classic literature; History of Neurology; Motor and non-motor evaluation; Non-motor symptoms; Pain; Parkinson's disease

Mesh:

Year:  2014        PMID: 24433931     DOI: 10.1016/j.jns.2014.01.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  26 in total

Review 1.  Epidemiology of Parkinson's disease.

Authors:  Ole-Bjørn Tysnes; Anette Storstein
Journal:  J Neural Transm (Vienna)       Date:  2017-02-01       Impact factor: 3.575

2.  Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2015-06-03       Impact factor: 4.530

3.  A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease.

Authors:  Brian P Dranka; Alison Gifford; Donna McAllister; Jacek Zielonka; Joy Joseph; Crystal L O'Hara; Cheryl L Stucky; Anumantha G Kanthasamy; Balaraman Kalyanaraman
Journal:  Neurosci Lett       Date:  2014-09-26       Impact factor: 3.046

4.  Sleep spindle alterations in patients with Parkinson's disease.

Authors:  Julie A E Christensen; Miki Nikolic; Simon C Warby; Henriette Koch; Marielle Zoetmulder; Rune Frandsen; Keivan K Moghadam; Helge B D Sorensen; Emmanuel Mignot; Poul J Jennum
Journal:  Front Hum Neurosci       Date:  2015-05-01       Impact factor: 3.169

5.  Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.

Authors:  Wiebke Grashorn; Odette Schunke; Carsten Buhmann; Katarina Forkmann; Sabrina Diedrich; Katharina Wesemann; Ulrike Bingel
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

6.  Increased DJ-1 in urine exosome of Korean males with Parkinson's disease.

Authors:  Dong Hwan Ho; Sanghak Yi; Hyemyung Seo; Ilhong Son; Wongi Seol
Journal:  Biomed Res Int       Date:  2014-11-13       Impact factor: 3.411

7.  Fatigue in Parkinson's disease: report from a mutidisciplinary symposium.

Authors:  Joseph H Friedman; James C Beck; Kelvin L Chou; Gracia Clark; Christopher P Fagundes; Christopher G Goetz; Karen Herlofson; Benzi Kluger; Lauren B Krupp; Anthony E Lang; Jao-Shin Lou; Laura Marsh; Anne Newbould; Daniel Weintraub
Journal:  NPJ Parkinsons Dis       Date:  2016-01-14

8.  Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.

Authors:  Christine Petschow; Lukas Scheef; Sebastian Paus; Nadine Zimmermann; Hans H Schild; Thomas Klockgether; Henning Boecker
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

9.  The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Authors:  Emmanuelle Schmitt; Paul Krack; Anna Castrioto; Helene Klinger; Amelie Bichon; Eugénie Lhommée; Pierre Pelissier; Valerie Fraix; Stephane Thobois; Elena Moro; Pablo Martinez-Martin
Journal:  Mov Disord Clin Pract       Date:  2018-03-23

10.  Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.

Authors:  Rodolphe Hajj; Aude Milet; Damien Toulorge; Nathalie Cholet; Julien Laffaire; Julie Foucquier; Sandra Robelet; Richard Mitry; Mickael Guedj; Serguei Nabirotchkin; Ilya Chumakov; Daniel Cohen
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.